Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC–MS: enhanced transport of Leu-enkephalin analogues
Introduction
Peptides and proteins are important potential therapeutic agents for a number of disease states. Hydrolytic instability in the gastrointestinal tract is a major limitation for the preferred oral route of administration of these compounds Lee and Yamamoto, 1990, Banga and Chien, 1988. Attachment of sugar units and lipoamino acids to peptides can increase the stability of a peptide towards degradation and increase the permeability of hydrophilic peptides across the intestinal membrane (Toth et al., 1999). Lipoamino acids are synthetic amino acids with a hydrophobic side chain that increases the lipophilicity of the compound to which it is attached, and have been used to increase the stability to degradation of a number of peptides (Wong and Toth, 2001). Conjugation of sugar units has also been used to increase the stability of peptides to degradation, mainly through protection of the N- or C-termninal end to which it is attached (Wong and Toth, 2001). A library of analogues can be synthesised by attaching these units at various positions in the peptide, usually the N- and C-termini. We have used the Caco-2 assay as an in vitro model to study intestinal epithelial transport of a number of peptide analogues. The human intestinal cell line Caco-2, spontaneously differentiates on microporous filter membranes forming monolayers with tight cellular junctions (Wilson et al., 1990). The permeability of compounds through the Caco-2 cell monolayer can be related to the extent of oral absorption in humans, which provides important information for selecting lead compounds for further study (Artursson and Karlsson, 1991). Detection of the concentration of drug passing through the Caco-2 monolayer is usually determined by following a radiolabelled drug. However, disadvantages of this technique include the cost and hazards of radiolabelled drugs and the problems of detecting degraded or metabolised radiolabelled compounds.
Liquid chromatography–electrospray ionisation mass spectrometry (LC–MS) has been used by a number of researchers to replace the usual quantitation techniques of radiolabelled drugs utilising liquid scintillation counting or liquid chromatography–ultraviolet (LC–UV) detection of unlabelled drugs Wang et al., 2000, Stevenson et al., 1999, Caldwell et al., 1998. LC–MS has shown increased sensitivity and selectivity over these conventional techniques for a number of standard drugs. As part of our work with lipoamino acid modified peptides, we analyse very hydrophobic compounds. In this study, we examined the use of LC–MS with the Caco-2 assay to test some Leu-enkephalin analogues, which vary in lipophilicity and discuss some of the difficulties in running very hydrophobic, poorly water-soluble compounds. Analysis of a water-soluble drug, cephalexin and modified Leu-enkephalin by both radioactivity measurement and LC–MS, confirms the applicability of our LC–MS protocol.
Section snippets
Chemicals
MBHA resin, Chloro Trityl resin, Rink amide resin and protected amino acids were obtained from Novabiochem (Melbourne, Australia). DMF and TFA of peptide synthesis grade were purchased from Auspep (Parkville, Australia). Caco-2 cells were obtained from American Type Culture Collection (Rockville, MD), Transwell polycarbonate insets were from Costar (Cambridge, MA) and cell culture reagents were purchased from Gibco-BRL (Grand Island, NY).
Synthesis
The radiolabelled acetylated cephalexin 1 and acetylated
Comparison of permeability via scintillation counting versus LC–MS
Table 2 shows the apparent permeability values obtained for the readily water soluble radiolabelled acetylated cephalexin 1 as determined by liquid scintillation counter, plus the permeabilities of acetylated cephalexin 2 and cephalexin 3 as quantitated by LC–MS. The permeability values obtained for 1 and 2 via the two different methods are statistically the same, as shown in Table 1. Whereas, acetylated 1 and the non-acetylated 3 are statistically different, most probably due to the increased
Discussion
Difficulties of analysing poorly water-soluble compounds have been overcome by the addition of DMSO (5%) and acidification of the standards and collected receiver solutions. This serves to prevent precipitation of peptides from the aqueous solution and in addition prevents disappearance of the peptides upon standing, which we have observed for solutions without acid and DMSO. This disappearance is attributed to binding of the peptide to the container surfaces, also observed by us for other
Conclusions
A rapid LC–MS method has been developed for determining the apparent permeabilities of compounds varying in lipophilicity in the Caco-2 cell assay (1–9). Problems associated with poor water solubility of the lipoamino acid-coupled peptides were overcome by acidification with formic acid (10%) and adding DMSO (5%) to the standards and samples collected after the transport experiments. Leu-enkephalin was rapidly degraded after contact with Caco-2 cells, however, sugar and sugar–lipoamino acid
Acknowledgements
This work was supported by a Wellcome Trust equipment grant 057160/Z/99.
References (17)
- et al.
Correlation between oral-drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
Biochem. Biophys. Res. Commun.
(1991) - et al.
Systemic delivery of therapeutic peptides and proteins
Int. J. Pharm.
(1988) - et al.
Solid phase synthesis of C-terminal carbohydrate modified enkephalins
Bioorg. Med. Chem. Lett.
(1997) - et al.
Synthesis and in vitro evaluation of lipoamino acid and carbohydrate-modified enkephalins as potential antinociceptive agents
Int. J. Pharm.
(1998) - et al.
Improvement of intestinal absorption of leucine enkephalin by sugar coupling and peptidase inhibitors
J. Pharm. Sci.
(1996) - et al.
Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures
Int. J. Pharm.
(1999) - et al.
Oral absorption of lipidic amino-acid conjugates
Int. J. Pharm.
(1994) - et al.
Lipidic conjugates of luteinizing-hormone-releasing hormone (Lhrh)+ and thyrotropin-releasing-hormone (Trh)+ that release and protect the native hormones in homogenates of human intestinal epithelial (Caco-2) cells
Int. J. Pharm.
(1994)
Cited by (21)
Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization
2019, Bioconjugate ChemistryMechanism of Drug-Drug Interactions between Warfarin and Statins
2016, Journal of Pharmaceutical SciencesPrediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks
2010, European Journal of Pharmaceutical SciencesModified low molecular weight cyclic peptides as mimetics of BDNF with improved potency, proteolytic stability and transmembrane passage in vitro
2009, Bioorganic and Medicinal ChemistrySynthesis and in vitro evaluation of a library of modified endomorphin 1 peptides
2008, Bioorganic and Medicinal ChemistryIn vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin
2008, Bioorganic and Medicinal Chemistry